Monte Change In Cash vs Depreciation Analysis

GLUE Stock  USD 8.49  0.14  1.68%   
Monte Rosa financial indicator trend analysis is infinitely more than just investigating Monte Rosa Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Monte Rosa Therapeutics is a good investment. Please check the relationship between Monte Rosa Change In Cash and its Depreciation accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Monte Rosa Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Change In Cash vs Depreciation

Change In Cash vs Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Monte Rosa Therapeutics Change In Cash account and Depreciation. At this time, the significance of the direction appears to have no relationship.
The correlation between Monte Rosa's Change In Cash and Depreciation is 0.05. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Depreciation in the same time period over historical financial statements of Monte Rosa Therapeutics, assuming nothing else is changed. The correlation between historical values of Monte Rosa's Change In Cash and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of Monte Rosa Therapeutics are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Change In Cash i.e., Monte Rosa's Change In Cash and Depreciation go up and down completely randomly.

Correlation Coefficient

0.05
Relationship DirectionPositive 
Relationship StrengthInsignificant

Change In Cash

Depreciation

Depreciation indicates how much of Monte Rosa Therapeutics value has been used up. For tax purposes Monte Rosa can deduct the cost of the tangible assets it purchases as business expenses. However, Monte Rosa Therapeutics must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.
Most indicators from Monte Rosa's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Monte Rosa Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Monte Rosa Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
As of November 25, 2024, Selling General Administrative is expected to decline to about 17.5 M. In addition to that, Tax Provision is expected to decline to about 185.9 K
 2021 2022 2023 2024 (projected)
Interest Expense1.1M3.8M4.3M4.5M
Depreciation And Amortization2.1M8.6M6.2M3.9M

Monte Rosa fundamental ratios Correlations

0.760.630.750.970.970.83-0.69-0.830.840.810.850.990.8-0.850.80.390.980.990.550.970.8-0.450.99-0.850.99
0.760.980.880.640.680.64-0.41-0.70.880.630.670.760.52-0.980.640.710.810.710.80.640.65-0.430.76-0.980.71
0.630.980.850.480.540.55-0.28-0.620.820.50.570.620.38-0.940.550.760.690.580.820.480.57-0.40.62-0.940.56
0.750.880.850.580.720.84-0.28-0.870.990.490.850.710.31-0.90.830.890.720.790.960.580.83-0.60.71-0.90.65
0.970.640.480.580.950.72-0.78-0.720.70.850.750.980.87-0.740.70.170.960.940.341.00.69-0.360.98-0.740.99
0.970.680.540.720.950.8-0.71-0.890.820.810.830.960.67-0.790.890.350.920.970.510.950.85-0.630.96-0.790.95
0.830.640.550.840.720.8-0.21-0.90.880.381.00.760.5-0.730.840.680.780.890.760.720.92-0.520.77-0.730.73
-0.69-0.41-0.28-0.28-0.78-0.71-0.210.36-0.38-0.97-0.25-0.77-0.650.49-0.420.19-0.66-0.630.01-0.78-0.260.2-0.760.49-0.79
-0.83-0.7-0.62-0.87-0.72-0.89-0.90.36-0.92-0.53-0.91-0.78-0.350.8-0.99-0.68-0.77-0.88-0.78-0.72-0.990.82-0.790.8-0.74
0.840.880.820.990.70.820.88-0.38-0.920.590.890.810.42-0.920.880.810.80.870.90.70.87-0.610.81-0.920.75
0.810.630.50.490.850.810.38-0.97-0.530.590.420.870.68-0.690.560.050.790.750.230.850.42-0.320.86-0.690.87
0.850.670.570.850.750.831.0-0.25-0.910.890.420.790.53-0.750.850.670.810.910.760.750.92-0.520.8-0.750.76
0.990.760.620.710.980.960.76-0.77-0.780.810.870.790.82-0.840.760.320.980.970.480.980.74-0.431.0-0.841.0
0.80.520.380.310.870.670.5-0.65-0.350.420.680.530.82-0.570.29-0.060.850.720.090.870.360.090.82-0.570.85
-0.85-0.98-0.94-0.9-0.74-0.79-0.730.490.8-0.92-0.69-0.75-0.84-0.57-0.74-0.69-0.88-0.81-0.79-0.74-0.750.52-0.841.0-0.8
0.80.640.550.830.70.890.84-0.42-0.990.880.560.850.760.29-0.740.620.720.850.720.70.96-0.870.76-0.740.72
0.390.710.760.890.170.350.680.19-0.680.810.050.670.32-0.06-0.690.620.370.450.980.170.67-0.510.32-0.690.24
0.980.810.690.720.960.920.78-0.66-0.770.80.790.810.980.85-0.880.720.370.940.520.960.75-0.390.98-0.880.97
0.990.710.580.790.940.970.89-0.63-0.880.870.750.910.970.72-0.810.850.450.940.60.940.85-0.50.97-0.810.95
0.550.80.820.960.340.510.760.01-0.780.90.230.760.480.09-0.790.720.980.520.60.340.76-0.560.48-0.790.41
0.970.640.480.581.00.950.72-0.78-0.720.70.850.750.980.87-0.740.70.170.960.940.340.69-0.350.98-0.740.99
0.80.650.570.830.690.850.92-0.26-0.990.870.420.920.740.36-0.750.960.670.750.850.760.69-0.80.75-0.750.71
-0.45-0.43-0.4-0.6-0.36-0.63-0.520.20.82-0.61-0.32-0.52-0.430.090.52-0.87-0.51-0.39-0.5-0.56-0.35-0.8-0.420.52-0.39
0.990.760.620.710.980.960.77-0.76-0.790.810.860.81.00.82-0.840.760.320.980.970.480.980.75-0.42-0.841.0
-0.85-0.98-0.94-0.9-0.74-0.79-0.730.490.8-0.92-0.69-0.75-0.84-0.571.0-0.74-0.69-0.88-0.81-0.79-0.74-0.750.52-0.84-0.8
0.990.710.560.650.990.950.73-0.79-0.740.750.870.761.00.85-0.80.720.240.970.950.410.990.71-0.391.0-0.8
Click cells to compare fundamentals

Monte Rosa Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Monte Rosa Therapeutics is a strong investment it is important to analyze Monte Rosa's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Monte Rosa's future performance. For an informed investment choice regarding Monte Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Monte Rosa Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monte Rosa. If investors know Monte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monte Rosa listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.78)
Revenue Per Share
0.221
Return On Assets
(0.28)
Return On Equity
(0.61)
The market value of Monte Rosa Therapeutics is measured differently than its book value, which is the value of Monte that is recorded on the company's balance sheet. Investors also form their own opinion of Monte Rosa's value that differs from its market value or its book value, called intrinsic value, which is Monte Rosa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monte Rosa's market value can be influenced by many factors that don't directly affect Monte Rosa's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monte Rosa's value and its price as these two are different measures arrived at by different means. Investors typically determine if Monte Rosa is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monte Rosa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.